All Articles

Banked cord blood and therapies like DUOC-01 show strong trial results—faster availability, lower rejection risk, and improved outcomes for many rare genetic disorders.

Cord blood and tissue stem cell therapies show early safety and promise for repairing lung and brain injuries in newborns with BPD, HIE, and IVH.

MSC therapies for degenerative disc disease: mechanisms, clinical results and safety, and emerging exosome, biomaterial, gene-editing, and stem cell banking advances.

Five essential questions—accreditation, storage, pricing, medical uses, and financial stability—to evaluate cord blood banks before your baby's birth.

Explains how cord blood banking preserves newborn stem cells for 80+ treatments today and supports future adult therapies through long-term storage.

Store cord blood (HSCs) and cord tissue (MSCs) to preserve blood, immune and regenerative stem cells for current treatments and future therapies.

Explains why higher cord blood and tissue stem cell yields improve transplant success, expand treatment options, and support future regenerative therapies.

How placental tissue—rich in MSCs, hAECs, and growth factors—complements cord blood for wound healing, orthopedics, neurology, and long-term banking.

MRI, PET/CT, and AI enable noninvasive, real-time tracking of transplanted stem cells—revealing viability, inflammation, and early indicators of success in autoimmune therapies.